Wednesday, May 19, 2010, 9:49 AM
Wesley J. Smith | Secondhand Smoke
Biotechnology has not been much in the news lately. Adult stem cell successes continue to be ignored by media and induced pluripotent stem cell research continues apace. There are no human trials approved for embryonic stem cells–despite years of promises by Geron and others, “Wait until next year!” Indeed, once the media lost its “destroy Bush!” obsession with the election of President Obama, who revoked Bush’s funding policy, the issue pretty much disappeared from the public discourse.
But it will be back. As I have repeatedly stated, the real agenda here isn’t stem cells. It is human cloning. But that sector has not thrived due to technical difficulties and the inability to engage in mass cloning due to a paucity of human eggs. But someday that may change. And when it does, billions and billions (as the late Carl Sagan used to say) of your dollars will be needed to pay for it. Read more.